Soung and Chung showed that the association of epigallocatechin gallate and curcumin has an efficacy outcome in both in vitro and in vivo models of ERα-breast cancer by the regulation of epidermal growth factor receptor expression [308]. The gene discussed is ESR1; the disease is breast cancer.